Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Teck K Khong"'
Autor:
Teck K Khong, George S Lin
Publikováno v:
Drug and Therapeutics Bulletin. 61:52-54
Commentary on:Mackenzie IS, Rogers A, Poulter NR,et al. Cardiovascular outcomes in adults with hypertension with evening vs morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clin
Autor:
Rochelle D Sylvester, Teck K Khong
Publikováno v:
Drug and Therapeutics Bulletin. :dtb-2023
Commentary on:Heerspink HJL, Stefánsson BV, Correa-Rotter R,et al. Dapagliflozin in patients with chronic kidney disease.N Engl J Med2020;383:1436–46.Series Editor:Dr Teck Khong, DTB Associate Editor, Clinical Pharmacology, St George’s, Universi
Autor:
Teck K Khong, Henry Fok
Publikováno v:
Drug and Therapeutics Bulletin. 59:119-123
Key learning points Hypertension affects 25% of the global population and is a major preventable cause of premature disability and mortality.1 Importantly, symptoms are usually absent and as a result patients are often undiagnosed and undertreated—
Autor:
Teck K Khong
Publikováno v:
Drug and Therapeutics Bulletin. 61:50-50
Autor:
Abubaker Eltayeb, Teck K Khong
Publikováno v:
Drug and therapeutics bulletin. 60(4)
Commentary on:Chow CK, Atkins ER, Hillis GS,et al. Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3,
Autor:
Teck K Khong
Publikováno v:
Drug and therapeutics bulletin. 59(12)
A recent government-commissioned report highlighting the extent of overprescribing in the UK has estimated, based on limited evidence, that at least 10% of medicines prescribed in primary care may be overprescribed.1 The report used the term overpres
Autor:
Elizabeth, Adeyeye, Teck K, Khong
Publikováno v:
Drug and Therapeutics Bulletin. :dtb-2022
Commentary on:Anker SD, Butler J, Filippatos G,et al. Empagliflozin in heart failure with a preserved ejection fraction.New England Journal of Medicine, 2021; 385:1451–61.
Autor:
Franca, Morselli, Teck K, Khong
Publikováno v:
Drug and Therapeutics Bulletin. 60:118-119
Commentary on:Sheppard JP, Burt J, Lown M,et al. Effect of antihypertensive medication reduction vs usual care on short-term blood pressure control in patients with hypertension aged 80 years and older: The OPTIMISE randomized clinical trial.JAMA. 20
Autor:
James Kimpton, Teck K Khong
Publikováno v:
Drug and therapeutics bulletin. 59(10)
Commentary on:Maron DJ, Hochman JS, Reynolds HR,et al. Initial Invasive or Conservative Strategy for Stable Coronary Disease.N Engl J Med. 2020;382:1395–1407.Series co-ordinator:Dr Teck Khong, DTB Associate Editor Clinical Pharmacology, St George's
Autor:
Joshua Au Yeung, Teck K Khong
Publikováno v:
Drug and therapeutics bulletin. 59(6)
Commentary on: McMurray JJV, Solomon SD, Inzucchi SE, et al Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 2019;381:1995-2008. Commentary by: Dr Joshua Au Yeunga, Clinical Pharmacology, St Thomas' Hospital, L